A5024229026- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Advances in Oncology and Radiotherapy
- Viral Infections and Outbreaks Research
- Colorectal Cancer Surgical Treatments
- Global Cancer Incidence and Screening
- Renal cell carcinoma treatment
- Hepatitis C virus research
- Renal and related cancers
- Safe Handling of Antineoplastic Drugs
- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- BRCA gene mutations in cancer
- Neutropenia and Cancer Infections
- Hepatitis B Virus Studies
- Medication Adherence and Compliance
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
Edward Hines, Jr. VA Hospital
2015-2023
Veterans Health Administration
2021
United States Department of Veterans Affairs
2021
Given the paucity of information on dose intensity, objective this study is to describe use adjuvant chemotherapy for stage III colon cancer, focusing relative intensity (RDI), overall survival (OS) and disease-free (DFS). Retrospective cohort 367 patients diagnosed with cancer in 2003–2008 treated at 19 VA medical centers. Kaplan-Meier curves summarize 5-year OS 3-year DFS by regimen RDI, multivariable Cox proportional hazards regression was used model these associations....
The treatment of cancer is associated with high risk for toxicity and cost. Strategies to enhance the value, quality, safety care are often managed independently one another. Oncology stewardship a potential framework unify these efforts outcomes. This landscape survey establishes baseline information on oncology in United States.
Hepatitis B virus (HBV) reactivation may occur with high risk immunosuppression, such as anti-cluster of differentiation (CD)20 antibodies (Abs). Appropriate HBV prophylaxis during anti-CD20 Ab therapy averts hepatitis, chemotherapy disruption, and death. Serologic evidence prior exposure is present in one nine veterans the Veterans Health Administration (VHA). In 2014, most (61%-73%) patients VHA who were receiving treatment underwent testing, yet <20% eligible received antiviral...
The objective of this study is to describe the use targeted therapies for treatment advanced renal cell carcinoma (RCC) and overall survival (OS) among patients in clinical practice Veterans Health Administration (VHA).A retrospective cohort 286 from 24 VHA Medical Centers diagnosed with clear RCC between Fiscal Year (FY) 2010 FY2014 was followed through September 30, 2016. Among who received therapy, we described medications taken, duration survival. We also assessed effect first therapy on...
e23219 Background: The Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Services created a national stewardship with focus on anti-cancer therapeutics within disease-specific cohort. Building model to common malignancy is novel approach. A toolkit was built containing resources support initiatives promote standardization practice and monitor outcomes as continual quality improvement process. This piloted in Veteran patients Chronic Myeloid Leukemia (CML) since Tyrosine...
Within the US Department of Veterans Affairs (VA), breast cancer prevalence has more than tripled from 1995 to 2012. Women veterans may be at an increased risk based on service-related exposures and posttraumatic stress disorder (PTSD).Women aged ≥ 35 years with no personal history were enrolled 2 urban VA medical centers. We surveyed women for 5-year lifetime risks invasive using Gail Breast Cancer Risk Assessment Tool (BCRAT). Data regarding demographics, PTSD status, eligibility...